Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma

Acta Odontologica Scandinavica

Volumn 69, Issue 6, 2011, Pages 406-409

  Saghravanian, Nasrollah ^a   Ghazvini, Kiarash ^b   Babakoohi, Shahab ^c   Firooz, Alireza ^c   Mohtasham, Nooshin ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

human papilloma virus; oral leukoplakia; oral squamous cell carcinoma; verrucous carcinoma

Indexed keywords

AGE; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; GENOTYPE; GINGIVA TUMOR; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; ISOLATION AND PURIFICATION; LEUKOPLAKIA; LIP TUMOR; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TONGUE TUMOR; VERRUCOUS CARCINOMA; VIROLOGY;

AGE FACTORS; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA, VERRUCOUS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GINGIVAL NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; LEUKOPLAKIA, ORAL; LIP NEOPLASMS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEX FACTORS; TONGUE NEOPLASMS;

EID: 80155135575     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.3109/00016357.2011.572560     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D,Mathers C, ParkinDM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr, accessed 23 March 2011.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45:309-16.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
4. Rautava J, Luukkaa M, Heikinheimo K, et al. Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol 2007;43:911-9.
5. Barnes L, Eveson JW, Reichard P, et al.WHOclassification of tumors. Pathology and genetics head and neck tumors. Lyon: IARC press; 2005. p 22-3.
6. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670-8.
7. McCoy JM, Waldron CA. Verrucous carcinoma of the oral cavity. A review of forty-nine cases. Oral Surg Oral Med Oral Pathol 1981;52:623-9.
8. Koch BB, Trask DK, Hoffman HT, et al. National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome. Cancer 2001;92:110-20.
9. Bouquot JE. Oral verrucous carcinoma. Incidence in two US populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:318-24.
10. Alkan A, Bulut E, Gunhan O, Ozden B. Oral verrucous carcinoma: a study of 12 cases. Eur J Dent 2010;4:202-7.
11. Cerero-Lapiedra R, Baladé-Martínez D, Moreno-López LA, et al. Proliferative verrucous leukoplakia: a proposal for diagnostic criteria.Med Oral Patol Oral Cir Bucal 2010;15:839-45.
12. Rsenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population - based case -control study in southern Sweden. Swed Dent J Suppl 2005;1:1-66.
13. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
14. Koyama K, Uobe K, Tanaka A. Highly sensitive detection of HPV-DNA in paraffin section of human oral carcinomas. J Oral Pathol Med 2007;36:18-24.
15. Campisi G, Panzarella V, Giuliani M, et al. Human papillomavirus: its identikit and controversial role in oral oncogenesis, premalignant and malignant lesion (Review). Int J Oncol 2007;30:813-23.
16. Munger K. The role of human papillomaviruses in human cancers. Front Biosci 2002;1:641-49.
17. Syrjänen KJ, Syrjänen SM, LambergMA, Pyrhönen S. Human papillomavirus (HPV) involvement in squamous cell lesions of the oral cavity. Proc Finn Dent Soc 1983;79:1-8.
18. Khovidhunkit SO, Buajeeb W, Sanguansin S, et al. Detection of human papillomavirus in oral squamous cell carcinoma, leukoplakia and lichen planus in thai patients. Asian Pac J Cancer Prev 2008;9:771-5.
19. Acay R, Rezende N, Fontes A, et al. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification. Oral Microbio Immunol 2008;23:271-4.
20. Termine N, Panzarella V, Falaschini S, et al. HPV in oral cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008;19:1681-90.
21. Liama-Martinz S, Esparza-Gomez G, Campo-Trapero J, et al. Genotypic determination by PCR-RELP of human papillomavirus in normal oral mucosa, oral leukoplakia and oral squamous cell carcinoma sample in Madrid (Spain). Anticancer Res 2008;28:3733-41.
22. Ting Y, Manos M. Detection and typing of genital human papillomaviruses. Polymerase chain reaction protocols: a guide to methods and applications. San Diego: Academic Press; 1990. p 356-67.
23. Snijders PJF, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the PCR permits the detection of a broud spectrum of human papillomavirus genotypes. J Gen Virol 1990;71:173-81.
24. Sotlar K, Diemer D, Dethleffs A, et al. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 2004;42:3176-84.
25. Lubbe J, Kormann A, Adams V, et al. HPV-11 and HPV-16- associated oral verrucous carcinoma. Dermatology 1996;192: 217-21.
26. Murao K, Kubo Y, Fukumoto D, et al. Verrucous carcinoma of the scalp associated with human papillomavirus Type 33. Dermatol Surg 2005;31:1363-5.
27. Kay P, Meehan K, Williamson AL. the use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomavirus in samples containing low copy number of viral DNA. J Virol Methods 2002;105:159-70.
28. Shillitoe EJ. Papillomavirusesas targets for cancer gene therapy. Cancer Gene Ther 2006;13:445-50.
29. Miller CS, Johnstone BM. Human papilomavirus as risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:622-35.
30. Syrjanen S. Human papilomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32(Suppl 1):59-66.
31. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papilomavirus types in head and neck quamous cell carcinomas worldwide: a systemic review. Cancer Epidemiol Biomaekers Prev 2005;14:467-75.
32. Sargolzaei S, Keykhaie MR, Moradi A, et al. The association of different genotypes of human papillomavirus with oral squamous cell carcinoma. J Dent School - Beheshti Univ Dent J 2005;23:438-48.
33. Ghaemmaghami SA, Khalilazar L, Eslami B. The association of different genotypes of human papillomavirus with malignant and premalignant oral lesions. J Dent School - Beheshti Univ Dent J 2003;20:628-40.
34. Fujita S, Sebna M, Kumatori A, et al. Human papillomavirus infection in oral verrucous carcinoma: genotyping analysis and inverse correlation with p53 expression. Pathobiology 2008;75: 257-64.
35. Szarka K, Tar I, Feher E, et al. Progressive increase oh human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increase malignant potential. Oral Microbiol Immunol 2009;24:314-8.
36. Began JV, Jimenez Y, Murillo J, et al. Lack of association between proliferative verrucous leukoplakia and human papilomavirus infection. J Oral Maxillofac Surg 2007;65:46-9.
37. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998:20:250-65.
38. Hansson BG, Rosenquist K, Antonson A, et al. Strong association between infectionwith human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125:1337-44.